Eli Lilly and Company (NYSE:LLY) is one of the best growth stocks to buy for the next 20 years. On February 18, Eli Lilly ...

Why aren't we talking about it more?

Feb 18 (Reuters) - Eli Lilly said on Wednesday its weight-loss drug, Zepbound, used with psoriasis treatment Taltz, showed ...

The results of 2 recent clinical trials combining the GLP-1 drug and the biologic reinforce the benefits of treating obesity ...

Eli Lilly and Company (NYSE: LLY) today announced positive topline results from the landmark TOGETHER-PsO open-label Phase 3b ...

Combination ixekizumab plus tirzepatide outperformed ixekizumab monotherapy for the treatment of both psoriasis and ...

"Understanding biologic therapy trajectories in Medicaid is important, given its distinct formulary restrictions and patient demographics," they concluded. "Interventions must not only address access ...

Concomitant ixekizumab and tirzepatide significantly improved skin clearance and weight reduction in adults with moderate to severe plaque psoriasis.

Researchers identified multiple gene signatures linked to psoriasis severity, body weight, and immune activity. These ...

A common strep throat infection can trigger guttate psoriasis by altering the behaviour of key immune cells, according to a ...

Kim Kardashian discovered psoriasis appearing on her legs back in 2011 and life changed for her ever since then.But the ...

The Gulliver-Gestalt-Psoriasis Area Severity Estimate (G2-PASE) was developed to address a longstanding challenge in ...